CD8A and neoplasm: Overall, there is clear evidence from these initial animal studies that DCV reduces tumor growth, can prolong survival, induces tumor-specific IFNγ and CTL responses, is associated with T-cell infiltration of tumors, particularly by CD8+ T cells, and results in long-lasting antitumoral memory that provides protection from tumor re-challenge.